CONNECT WITH US
HealthTech

HealthTech

CDC names the 4 most dangerous superbugs in the US

Medical Xpress logo

Published on

Add as a preferred source on Google
CDC names the 4 most dangerous superbugs in the US

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Superbugs cause an estimated 9.7 million infections and 50,800 deaths in the United States each year.

Those figures come from a new report from the U.S. Centers for Disease Control and Prevention (CDC) that names 19 drug-resistant germs as threats, The Washington Post reports.

Superbugs are bacteria and fungi that have learned to survive the drugs designed to kill them. Their infections can be tough, and sometimes impossible, to treat, the CDC says.

The new totals are higher than in the CDC's 2019 superbug report, although the agency says some of the change reflects new measurement methods.

Germs picked up in hospitals and other medical settings cause more than 42,000 yearly deaths and add nearly $12 billion in health care costs.

"Antimicrobial resistance threatens modern medicine and puts millions of Americans at risk every year," CDC Director Dr. Erica Schwartz said in a statement.

The CDC ranks four germs as urgent threats, its most dangerous category:

Carbapenems are powerful antibiotics that doctors often save for when nothing else works. Another 13 germs pose serious threats, two are concerning and six more are on a watch list.

Dr. Helen Chu, an infectious disease physician at the University of Washington in Seattle, has seen more severe infections among her hospitalized patients, including gonorrhea and necrotizing fasciitis, a tissue-destroying infection.

"We saw an uptick of these cases in the last few years, the 'flesh-eating bacteria' that we worry about," Chu told The Post.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.